Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban M Abella

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinics in Laboratory Medicine|September 1, 2005
Current issues in pediatric stem cell transplantationSüreyya Savaşan, Esteban M Abella
The Annals of Pharmacotherapy|November 28, 2002
Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantationRami B Ibrahim, Esteban M Abella, Pranathathi H Chandrasekar
The Annals of Pharmacotherapy|August 28, 2002
Enoxaparin safety in patients with severe thrombocytopeniaRami B Ibrahim, Laurel E Stroempl, Esteban M Abella, et al.
The Annals of Pharmacotherapy|April 29, 2004
Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicityRami B Ibrahim, Edward Peres, Roger Dansey, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastomaHelen Dimaras, Diane Rushlow, William Halliday, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinics in Laboratory Medicine|September 1, 2005
Current issues in pediatric stem cell transplantationSüreyya Savaşan, Esteban M Abella
The Annals of Pharmacotherapy|November 28, 2002
Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantationRami B Ibrahim, Esteban M Abella, Pranathathi H Chandrasekar
The Annals of Pharmacotherapy|August 28, 2002
Enoxaparin safety in patients with severe thrombocytopeniaRami B Ibrahim, Laurel E Stroempl, Esteban M Abella, et al.
The Annals of Pharmacotherapy|April 29, 2004
Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicityRami B Ibrahim, Edward Peres, Roger Dansey, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastomaHelen Dimaras, Diane Rushlow, William Halliday, et al.
Pageof 1